Mutant Prevention Concentration of Isoniazid, Rifampicin and Rifabutin against Mycobacterium tuberculosis

Publisher： Karger

E-ISSN： 1421-9794|51|2-3|76-79

ISSN： 0009-3157

Source： Chemotherapy, Vol.51, Iss.2-3, 2005-06, pp. : 76-79

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efflux Activity Differentially Modulates the Levels of Isoniazid and Rifampicin Resistance among Multidrug Resistant and Monoresistant Mycobacterium tuberculosis Strains

By Machado Diana   Perdigão João   Portugal Isabel   Pieroni Marco   Silva Pedro A.   Couto Isabel   Viveiros Miguel  

Antibiotics, Vol. 7, Iss. 1, 2018-03 ,pp. : 18-18

MDPI

Access to resources Recommend Favorite

Experimental in vitro Efficacy Study on the Interaction of Epiroprim plus Isoniazid against Mycobacterium tuberculosis

By  

Chemotherapy, Vol. 47, Iss. 2, 2001-02 ,pp. : 123-127

Karger

Access to resources Recommend Favorite

Determination of the Mutant Prevention Concentration and the Mutant Selection Window of Topical Antimicrobial Agents against Propionibacterium acnes

By  

Chemotherapy, Vol. 62, Iss. 2, 2016-10 ,pp. : 94-99

Karger

Access to resources Recommend Favorite

Nutrient-Starved Incubation Conditions Enhance Pyrazinamide Activity against Mycobacterium tuberculosis

By  

Chemotherapy, Vol. 53, Iss. 5, 2007-09 ,pp. : 338-343

Karger

Access to resources Recommend Favorite

Evaluation of Pseudopteroxazole and Pseudopterosin Derivatives against Mycobacterium tuberculosis and Other Pathogens

By McCulloch Malcolm W. B.   Haltli Brad   Marchbank Douglas H.   Kerr Russell G.  

Marine Drugs, Vol. 10, Iss. 8, 2012-08 ,pp. : 1711-1728

MDPI

Access to resources Recommend Favorite